{"entity":{"type":"insider","cik":"0001951238","url":"/insider/0001951238","json_url":"/insider/0001951238.json","name":"Chakma Justin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":6,"first":"2024-11-27","last":"2025-11-14","span_basis":"filed_date"},"name_variants":[{"name":"Chakma Justin","source":"filing","n_filings":6,"first_seen":"2024-11-27","last_seen":"2025-11-14"}],"transactions":[{"id":5135700,"accession":"0001951238-25-000005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001951238-25-000005","line_url":"/filing/0001951238-25-000005","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001951238","owner_name":"Chakma Justin","owner_display_name":"Chakma Justin","owner_url":"/insider/0001951238","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":166380.0,"shares_display":"166,380","price_per_share":8.872145041471331,"price_display":"8.87","price_state":"stated","total_value":1476147.492,"total_display":"1,476,147.49","total_whole":"1,476,147","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-12","filed_date":"2025-11-14","scope":"insider","n_lines":2},{"id":2257708,"accession":"0001415889-24-029377","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-029377","line_url":"/filing/0001415889-24-029377#line-4","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001951238","owner_name":"Chakma Justin","owner_display_name":"Chakma Justin","owner_url":"/insider/0001951238","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27272.0,"shares_display":"27,272","price_per_share":12.0625,"price_display":"12.06","price_state":"stated","total_value":328968.5,"total_display":"328,968.50","total_whole":"328,969","shares_owned_after":136380.0,"shares_owned_after_display":"136,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-13","filed_date":"2024-12-13","scope":"insider"},{"id":2257702,"accession":"0001415889-24-029377","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-029377","line_url":"/filing/0001415889-24-029377#line-2","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001951238","owner_name":"Chakma Justin","owner_display_name":"Chakma Justin","owner_url":"/insider/0001951238","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":117333.0,"shares_display":"117,333","price_per_share":12.2653,"price_display":"12.27","price_state":"stated","total_value":1439124.4449,"total_display":"1,439,124.44","total_whole":"1,439,124","shares_owned_after":136380.0,"shares_owned_after_display":"136,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-12","filed_date":"2024-12-13","scope":"insider"},{"id":2807886,"accession":"0001415889-24-029162","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-029162","line_url":"/filing/0001415889-24-029162#line-2","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001951238","owner_name":"Chakma Justin","owner_display_name":"Chakma Justin","owner_url":"/insider/0001951238","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":13.1525,"price_display":"13.15","price_state":"stated","total_value":657625.0,"total_display":"657,625.00","total_whole":"657,625","shares_owned_after":136380.0,"shares_owned_after_display":"136,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-10","filed_date":"2024-12-12","scope":"insider"},{"id":2565681,"accession":"0001415889-24-028567","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-24-028567","line_url":"/filing/0001415889-24-028567#line-6","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001951238","owner_name":"Chakma Justin","owner_display_name":"Chakma Justin","owner_url":"/insider/0001951238","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":14.2323,"price_display":"14.23","price_state":"stated","total_value":711615.0,"total_display":"711,615.00","total_whole":"711,615","shares_owned_after":136380.0,"shares_owned_after_display":"136,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-06","filed_date":"2024-12-06","scope":"insider"},{"id":2565672,"accession":"0001415889-24-028567","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-028567","line_url":"/filing/0001415889-24-028567#line-4","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001951238","owner_name":"Chakma Justin","owner_display_name":"Chakma Justin","owner_url":"/insider/0001951238","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49640.0,"shares_display":"49,640","price_per_share":14.1346,"price_display":"14.13","price_state":"stated","total_value":701641.544,"total_display":"701,641.54","total_whole":"701,642","shares_owned_after":136380.0,"shares_owned_after_display":"136,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-05","filed_date":"2024-12-06","scope":"insider"},{"id":2565664,"accession":"0001415889-24-028567","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-028567","line_url":"/filing/0001415889-24-028567#line-2","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001951238","owner_name":"Chakma Justin","owner_display_name":"Chakma Justin","owner_url":"/insider/0001951238","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":13.9543,"price_display":"13.95","price_state":"stated","total_value":627943.5,"total_display":"627,943.50","total_whole":"627,944","shares_owned_after":136380.0,"shares_owned_after_display":"136,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-04","filed_date":"2024-12-06","scope":"insider"},{"id":3001342,"accession":"0001415889-24-028351","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-24-028351","line_url":"/filing/0001415889-24-028351#line-5","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001951238","owner_name":"Chakma Justin","owner_display_name":"Chakma Justin","owner_url":"/insider/0001951238","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":13.1867,"price_display":"13.19","price_state":"stated","total_value":593401.5,"total_display":"593,401.50","total_whole":"593,402","shares_owned_after":136380.0,"shares_owned_after_display":"136,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-03","filed_date":"2024-12-04","scope":"insider"},{"id":3001331,"accession":"0001415889-24-028351","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-028351","line_url":"/filing/0001415889-24-028351#line-2","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001951238","owner_name":"Chakma Justin","owner_display_name":"Chakma Justin","owner_url":"/insider/0001951238","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":13.6715,"price_display":"13.67","price_state":"stated","total_value":615217.5,"total_display":"615,217.50","total_whole":"615,218","shares_owned_after":136380.0,"shares_owned_after_display":"136,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-04","scope":"insider"},{"id":2807704,"accession":"0001415889-24-027843","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-027843","line_url":"/filing/0001415889-24-027843#line-3","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001951238","owner_name":"Chakma Justin","owner_display_name":"Chakma Justin","owner_url":"/insider/0001951238","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":14.39,"price_display":"14.39","price_state":"stated","total_value":359750.0,"total_display":"359,750.00","total_whole":"359,750","shares_owned_after":136380.0,"shares_owned_after_display":"136,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-27","filed_date":"2024-11-27","scope":"insider"},{"id":2807698,"accession":"0001415889-24-027843","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-027843","line_url":"/filing/0001415889-24-027843#line-2","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001951238","owner_name":"Chakma Justin","owner_display_name":"Chakma Justin","owner_url":"/insider/0001951238","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42186.0,"shares_display":"42,186","price_per_share":14.0466,"price_display":"14.05","price_state":"stated","total_value":592569.8676,"total_display":"592,569.87","total_whole":"592,570","shares_owned_after":161380.0,"shares_owned_after_display":"161,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-26","filed_date":"2024-11-27","scope":"insider"},{"id":2807692,"accession":"0001415889-24-027843","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-027843","line_url":"/filing/0001415889-24-027843#line-1","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001951238","owner_name":"Chakma Justin","owner_display_name":"Chakma Justin","owner_url":"/insider/0001951238","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32814.0,"shares_display":"32,814","price_per_share":14.0008,"price_display":"14.00","price_state":"stated","total_value":459422.2512,"total_display":"459,422.25","total_whole":"459,422","shares_owned_after":203566.0,"shares_owned_after_display":"203,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-25","filed_date":"2024-11-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001671858","name":"ARS Pharmaceuticals, Inc.","url":"/issuer/0001671858","role":"Officer (Chief Business Officer)","n_filings":6,"first_seen":"2024-11-27","last_seen":"2025-11-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001951238","retrieved_at":"2026-08-24T17:36:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}